The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial.
暂无分享,去创建一个
Terry L. Smith | G. Hortobagyi | S. Singletary | F. Ames | R. Theriault | A. Buzdar | F. Holmes | D. Frye | G. Fraschini | M. Mcneese | E. Thomas | R. Walters | T. Smith